Clinical Fellow in Haematology Early Phase Clinical Trials

Applications are invited for a Clinical Fellow (ST3+) in Haematology Early Phase Clinical Trials from August 2025. The aim of this position is to offer comprehensive specialist training in all aspects of running early phase haematology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings.

This full-time, fixed-term post will be for a period of 12 months from August 2025. Eligibility for full GMC Registration is essential and possession of MRCP or equivalent is necessary., Specialist training in haematology or oncology and competency in prescribing chemotherapy is required, experience in clinical trial work is desirable.

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites:

• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing), We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.

£61,825 to £70,425 a year Per annum + London weighting ( No on call commitments)